MedTrace Logo

Evaluation of a Novel Method of Contrast Volume Quantification - AVERT PLUS 2.0

NCT02578173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-06-21

No results posted yet for this study

Summary

Purpose: To evaluate the accuracy of the AVERT PLUS to monitor contrast volume used during angiographic procedures. This will be a first in man prospective observational study of the accuracy of this system to quantify contrast volume used during clinically indicated angiography in the cardiac catheterization laboratory.

Conditions

Interventions

DEVICE

AVERT PLUS

Sponsors & Collaborators

  • Anand Prasad

    lead OTHER

Principal Investigators

  • Michele Shepard · Osprey Medical, Inc

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-03-31
Completion
2016-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02578173 on ClinicalTrials.gov